SCHEMBL30132046

SCHEMBL30132046

COCOc1cc(-c2ncsn2)ccc1-c1cnc(SC)nn1

nearest known ligand 0.37

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
EGFR P00533 3/20 0.37
XDH P47989 1/20 0.33
FYN P06241 1/20 0.31
PDE4B Q07343 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25885043 1.00 EGFR (0.37) EGFRXDHFYNPDE4B
SCHEMBL30132040 0.82 EGFR (0.36) EGFRXDHPDE4B
SCHEMBL25885038 0.82 EGFR (0.36) EGFRXDHPDE4B
SCHEMBL30275015 0.79 EGFR (0.35) EGFRXDH
SCHEMBL21412242 0.78 MAPK1 (0.35) EGFR
SCHEMBL30131990 0.78 MAPK1 (0.35) EGFR
SCHEMBL25313346 0.72 HTT (0.51)
SCHEMBL30132015 0.72 HTT (0.51)
SCHEMBL30132080 0.71 DGAT1 (0.36)
SCHEMBL21412239 0.71 DGAT1 (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4132923-A1 COMPOUNDS FOR TREATING HUNTINGTON'S DISEASE PTC Therapeutics, Inc. (US) 2023-02-15 EP disclosed